“Conclusions: Combined therapy of Telmisartan and omega 3-fatty acids attenuated VED, by activating enzyme nitric oxide synthase (eNOS) through opening of ATP-sensitive K+ channels.”
“The … with Telmisartan (10 mg/…/day) and omega 3-fatty acids (180 mg/kg/day) (% Rmax=80.93, 13.09 µM/mg protein, 25.93 μg/mg of protein, 57.… units/mg protein and 0.08 µM/mg protein, respectively) significantly abolished the respective derangements induced by sodium arsenite.”